TCTE3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.153000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.766200E-01
Normal-vs-Stage2
4.024800E-01
Normal-vs-Stage3
2.962800E-01
Normal-vs-Stage4
2.812800E-01
Stage1-vs-Stage2
3.847400E-01
Stage1-vs-Stage3
1.389810E-01
Stage1-vs-Stage4
6.298800E-01
Stage2-vs-Stage3
1.351960E-01
Stage2-vs-Stage4
9.769000E-01
Stage3-vs-Stage4
2.185800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.206600E-01
Normal-vs-AfricanAmerican
3.756600E-01
Normal-vs-Asian
4.210600E-01
Caucasian-vs-AfricanAmerican
5.731200E-01
Caucasian-vs-Asian
9.796000E-01
AfricanAmerican-vs-Asian
5.254600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.137800E-01
Normal-vs-Female
4.206400E-01
Male-vs-Female
8.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.389200E-01
Normal-vs-Age(41-60Yrs)
4.197200E-01
Normal-vs-Age(61-80Yrs)
4.165800E-01
Normal-vs-Age(81-100Yrs)
4.025400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.549800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.025800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.862600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.139200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.796800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.194400E-01
Normal-vs-Daily Drinker
3.802800E-01
Normal-vs-Weekly Drinker
3.714200E-01
Normal-vs-Occasional Drinker
3.125200E-01
Normal-vs-Social Drinker
4.765000E-01
Non Drinker-vs-Daily Drinker
3.806200E-01
Non Drinker-vs-Weekly Drinker
3.196200E-01
Non Drinker-vs-Occasional Drinker
6.436000E-01
Non Drinker-vs-Social Drinker
3.297200E-01
Daily Drinker-vs-Weekly Drinker
8.398400E-01
Daily Drinker-vs-Occasional Drinker
4.246800E-01
Daily Drinker-vs-Social Drinker
7.871800E-02
Weekly Drinker-vs-Occasional Drinker
3.771000E-01
Weekly Drinker-vs-Social Drinker
4.867900E-02
Occasional Drinker-vs-Social Drinker
9.772400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.826800E-01
Normal-vs-Grade 2
4.555800E-02
Normal-vs-Grade 3
1.464240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.527190E-01
Grade 1-vs-Grade 3
3.203000E-01
Grade 1-vs-Grade 4
2.826800E-01
Grade 2-vs-Grade 3
4.265200E-01
Grade 2-vs-Grade 4
4.555800E-02
Grade 3-vs-Grade 4
1.464240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.855800E-01
Normal-vs-NonDiabetic
4.248600E-01
Diabetic-vs-NonDiabetic
3.397000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.370400E-01
Normal-vs-NoPancreatitis
4.069200E-01
Pancreatitis-vs-NoPancreatitis
7.030600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.437040E-01
Normal-vs-N1
3.861600E-01
N0-vs-N1
5.575900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.207200E-01
Normal-vs-TP53-NonMutant
5.171800E-01
TP53-Mutant-vs-TP53-NonMutant
7.624400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
